Last Updated: August 2, 2026

CORZIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Corzide, and when can generic versions of Corzide launch?

Corzide is a drug marketed by King Pharms Llc and is included in one NDA.

The generic ingredient in CORZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CORZIDE?
  • What are the global sales for CORZIDE?
  • What is Average Wholesale Price for CORZIDE?
Summary for CORZIDE
US Patents:0
Applicants:1
NDAs:1

US Patents and Regulatory Information for CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CORZIDE

See the table below for patents covering CORZIDE around the world.

Country Patent Number Title Estimated Expiration
Argentina 198638 PROCEDIMIENTO PARA PREPARAR 2,3-TRANS-1, 2, 3, 4-TETRAHIDRO-5--2,3-NAFTALENODIOLES ⤷  Start Trial
Argentina 198639 PROCEDIMIENTO PARA PREPARAR 2,3- CIS -1, 2, 3, 4-TETRAHIDRO-5--2,3-NAFTALENODIOLES ⤷  Start Trial
Belgium 849191 ⤷  Start Trial
Canada 979912 TETRAHYDRONAPHTHYLOXYAMINOPROPANOLS AND RELATED COMPOUNDS ⤷  Start Trial
Canada 979926 TETRAHYDRONAPHTHYLOXY-AMINOPROPANOLS AND RELATED COMPOUNDS ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.